Savient Pharmaceuticals files for bankruptcy - NJBIZ

10/15/13


Drug Discovery & Development

Savient Pharmaceuticals files for bankruptcy
NJBIZ
Savient said a final sale approval hearing is expected to take place after the auction with closing anticipated by the end of 2013. Savient filed its bankruptcy in federal court in Wilmington, Del. The company lists $260 million in debt and $74 million ...
Gout Drug's Sales Flop Lands Savient Pharma in Chapter 11Xconomy
Savient Pharmaceuticals Commences Voluntary Chapter 11 Proceeding; Seeks ...SYS-CON Media (press release)
Savient Files Chapter 11; Krystexxa to Remain AvailableBioWorld Online
Equities.com
all 26 news articles »

[more]